> ¼Ò½ÄÁö > ÇÐȸÇà»ç¼Ò½Ä
°¡À»Çмú´ëȸ´Â 2024³â 9¿ù 26ÀÏ(±Ý)°ú 27ÀÏ(Åä)¿¡ °ÉÃÄ ¼Ò³ëį ¿©¼ö ±×·£µåº¼·ë¿¡¼ ÁøÇàµÇ¾ú½À´Ï´Ù.
¸ðµÎ 314 ¸í(Àü¹®ÀÇ 153 ¸í, Àü°øÀÇ 34 ¸í, ¼¼Æ÷º´¸®»ç 122¸í, µ¿¹Ý°¡Á· 5¸í)ÀÌ µî·ÏÇÏ¿´½À´Ï´Ù.
Ư° ¹× ½ÉÆ÷Áö¿ò ³»¿ëÀº ´ÙÀ½°ú °°½À´Ï´Ù.
1) Ư° I
Pancreaticobiliary tract cytology: Àå±âÅà (¼º±Õ°üÀÇ´ë)
2) ½ÉÆ÷Áö¾ö I: Pancreaticobiliary tract cytology
LBC in Pancreaticobiliary tract cytology: ±è¹éÈñ (°í·ÁÀÇ´ë)
Pancreas FNA cytology: ³ªÈñ¿µ (¼¿ïÀÇ´ë)
Ancillary tests for pancreaticobiliary tract cytology: ³²ÁöÇØ (¿¬¼¼ÀÇ´ë)
Bile duct brush cytology: ÃÖÇýÁ¤ (¿ï»êÀÇ´ë)
3) Ư° II: Digital cytology and AI landscape: Recent Update
4) ¼¼Æ÷ Áø´ÜÀ» À§ÇÑ º´¸® ±³À° ÇÁ·Î±×·¥
Infectious disease and miscellaneous benign lesions in GYN pathology: ³ë¼Û¹Ì (Â÷ÀǰúÇдë)
5) ½ÉÆ÷Áö¾ö II: ºÎÀΰú ¼¼Æ÷º´¸®
Endocervical glandular lesions: ½ÅÁØ¿µ (±¹¸³¾Ï¼¾ÅÍ)
Endometrial glandular lesions: ¹ÚÈñÁ¤ (¿¬¼¼ÀÇ´ë)
ÇÐȸ ÃÑȸ¿¡¼´Â Çмú»ó ½Ã»óÀÌ ÀÖ¾ú½À´Ï´Ù.
´ë»óÀº ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¤¿ä¼Á ȸ¿øÀÌ
¨çImproved Diagnostic Accuracy of Thyroid Fine-Needle Aspiration Cytology with Artificial Intelligence Technology, Thyroid2024 34(6):723-734 (IF:6.7),
¨èArtificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid, Cancers2024 16(5):1064 (IF:4.4)
³í¹®À¸·Î ¼ö»óÇÏ¿´½À´Ï´Ù.
¿ì¼ö»óÀº ºÐ´ç¼¿ï´ëº´¿ø ³ªÈñ¿µ ȸ¿ø°ú ¼¿ï´ëÇб³ º´¿øÀÇ À¯ÇѼ® ȸ¿øÀÌ ¼ö»óÇÏ¿´À¸¸ç ³í¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.
³ªÈñ¿µ ȸ¿ø; Fine needle aspiration cytology diagnoses of follicular thyroid carcinoma: results from a multicenter study in Asia, PTM2024; 58: 331-340,
À¯ÇѼ® ȸ¿ø;
¨çComparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection, Pathobiology2024;91(5):359-369,
¨èDiscrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers, Pathobiology2024;91(3):169-179,
¨éExpression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma, Diagnostic Cytopathology2024 Feb;52(2):69-75.
ÇмúÀå·Á»ó(JPTM¼¼Æ÷³í¹® ÃÖ´Ù°ÔÀç»ó)Àº ´ë»óÀÚ°¡ ¾ø¾ú½À´Ï´Ù.
Æ÷½ºÅÍ»ó ½Ã»ó¿¡¼ ÃÖ¿ì¼ö Æ÷½ºÅÍ»óÀº ÀÌÀ¯Áø (°¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø), ¿ì¼öÆ÷½ºÅÍ»óÀº ¿À½ÂÁÖ (¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø), ¹®Áöȯ ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø), Á¤¿ä¼Á (°¡Å縯´ëÇб³ ÀÇÁ¤ºÎ¼º¸ðº´¿ø) Áõ·Ê ¿ì¼öÃÊ·Ï»óÀº Á¤¿¹½½ (°¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø) ȸ¿øÀÌ ¼ö»óÇÏ¿´½À´Ï´Ù.
27ÀÏ(Åä)¿¡´Â ÇÑÀÏÇмú´ëȸ(The 22nd Korea-Japan Joint Meeting for Diagnostic Cytopathology)°¡ °³ÃֵǾú½À´Ï´Ù.
ÀϺ»Ãø Âü¼®ÀÚ´Â 21¸í (Àü¹®ÀÇ 13¸í, ¼¼Æ÷º´¸®»ç 8¸í)À̾ú½À´Ï´Ù.
Plenary lecture ÁÖÁ¦´Â ´ÙÀ½°ú °°¾Ò½À´Ï´Ù.
Implementation and Evaluation of the New WHO Reporting System for Lung Cytopathology
- Prof. Yuko Minami (National Hospital Organization Ibarakihigashi National Hospital)
Diagnostic & Prognostic Biomarkers in Cytology: Multiorgan Perspectives
- Prof. Han Suk Ryu (Seoul National Univ. Hospital)
